Cost of epilepsy in Hong Kong: Experience from a regional hospital

Seizure

Volumn 8, Issue 8, 1999, Pages 456-464

  Mak, W ^a   Fong, J K Y ^a   Cheung, R T F ^a   Ho, S L ^a  

^a NONE

Author keywords

China; Cost of epilepsy; Cost of illness; Epilepsy; Hong Kong

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ABSENTEEISM; ARTICLE; DRUG COST; ECONOMIC EVALUATION; EPILEPSY; EXPERIENCE; HEALTH CARE COST; HONG KONG; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PRODUCTIVITY; REMISSION; RETROSPECTIVE STUDY; UNEMPLOYMENT;

EID: 0033394364     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.1999.0343     Document Type: Article

References (33)

1. R. G. Beran, C. H. (Eds), Pachlatko, Proceedings of the 20th International Epilepsy Congress, 1995, Ciba-Geigy Verlag, Wehr/Baden.
2. Beran R. G., Pachlatko C. Reports of the International League against epilepsy commission on economic aspects of epilepsy. Epilepsia. 37:1996;506-508.
3. Begley C. E., Annegers J. F., Lairson D. R., Reynolds T. F., Hauser W. A. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia. 35:1994;1230-1243.
4. Murray M. I., Halpern M. T., Leppik I. E. Cost of refractory epilepsy in adults in the USA. Epilepsy Research. 23:1996;139-148.
5. Cockerell O. C., Hart Y. M., Sander W. A. S., Shorvon S. D. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Research. 18:1994;249-260.
6. Beran R. G., Regan K. J. The prevalence and cost of epilepsy in Australia. Epilepsia. 34 (Suppl. 2):1993;146.
7. Silfvenius H. Economic costs of epilepsy - treatment benefits. Acta Neurologica Scandinavica Supplement. 117:1988;136-154.
8. Weibe S., Gafni A., Blume W. T., Girvin J. P. An economic evaluation of surgery for temporal lobe epilepsy. Journal of Epilepsy. 8:1995;227-235.
9. King J. T., Sperling M. R., Justice A. C., O'Connor M. J. A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. Journal of Neurosurgery. 87:1997;20-28.
10. Li S. C., Schoenberg B. S., Wang C. C., Cheng X. M., Zhou S. S., Bolis C. L. Epidemiology of epilepsy in urban areas of the People's Republic of China. Epilepsia. 26:1985;391-394.
11. Lancet. 337:1991;1175-1180.
12. Beck J. R., Kassirer J. P., Pauker S. G. A convenient approximation of life expectancy (The 'DEALE'). 1. Validation of the method. American Journal of Medicine. 73:1982;883-888.
13. Beck J. B., Pauker S. G., Gottlieb J. E., Klein K., Kassirer J. P. A convenient approximation of life expectancy (The 'DEALE'). 2. Use in medical decision-making. American Journal of Medicine. 73:1982;889-897.
14. A Practical Guide to Prevent Effectiveness: Decision and Economic Analyses.
15. A Guide to Services of Public Hospitals, Hong Kong, Hospital Authority.
16. Chadwick D., Reynolds E. H. Services for epilepsy in the United Kingdom. Neurology. 48 (Suppl. 8):1997;S3-S7.
17. Willmore L. J. Care of adults with epilepsy in the United States. Neurology. 48 (Suppl. 8):1997;S39-S43.
18. Van Hout B., Gagnon D., Souetre E., et al. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia. 38:1997;1221-1226.
19. Mandelblatt J. S., Fryback D. G., Weinstein M. C., Russel L. B., Gold M. R., Hadorn D. C. Assessing the effectiveness of health interventions. Gold M. R., Siegel J. E., Weinstein L. B., et al. Cost-Effectiveness in Health and Medicine. 1996;Oxford University Press, New York.
20. O'Neil B. A., Trimble M. R., Bloom D. S. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of alternative treatment options. Seizure. 4:1995;37-44.
21. Hughes D., Cockerell O. C. A cost minimization study comparing vigabatrin, lamotrigine and gabapentin for the treatment of intractable partial epilepsy. Seizure. 5:1996;89-95.
22. Rice D. P. Cost-of-illness studies: fact or fiction? Lancet. 344:1994;1519-1520.
23. Wagner A. K., Vickrey B. G. The routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda. Quality of Life Research. 4:1995;169-177.
24. Vickrey B. G., Hays R. D., Engel J., et al. Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Annals of Neurology. 37:1995;158-166.
25. Begley C. E., Annegers J. F., Lairson D. R., Reynolds T. F. Methodological issues in estimating the cost of epilepsy. Epilepsy Research. 33:1999;39-55.
26. Baker G. A. Health-related quality-of-life issues: optimizing patient outcomes. Neurology. 45 (Suppl. 2):1995;S29-S34.
27. Plan for Nationwide Action on Epilepsy. 1978;DHEW Publication, Washington.
28. Thompson P., Oxley J. Social aspects of epilepsy. Laidlaw J., Richens A. A., Chadwick D. D. A Textbook of Epilepsy. 1993;Churchill Livingstone, Edinburgh.
29. Williams K. L., Roth D. L., Kuznieck R., et al. Psychosocial outcome following temporal lobe surgery. Journal of Epilepsy. 7:1994;144-151.
30. Sperling M. R., Saykin A. J., Roberts B. S. W., French J. A., O'Connor M. J. Occupational outcome after temporal lobectomy for refractory epilepsy. Neurology. 45:1995;970-977.
31. Kellet M. W., Smith D. F., Baker G. A., Chadwick D. W. Quality of life after epilepsy surgery. Journal of Neurology, Neurosurgery, and Psychiatry. 63:1997;52-58.
32. Lendt M., Helmstaedter C., Elger C. E. Pre- and postoperative socioeconomic development of 151 patients with focal epilepsy. Epilepsia. 38:1997;1330-1337.
33. Chadwick D. Measuring antiepileptic therapies: the patient vs the physician viewpoint. Neurology. 44 (Suppl. 8):1994;S24-S28.